Guardant Health, Inc. (NASDAQ:GH) Q2 2023 Earnings Call Transcript

Unidentified Analyst: Great. This is Casey, we’re doing on for Rachel and squeezing it then. So I guess just two quick ones for you. On the CDx side, can you talk about what’s the next pipeline in terms of maybe other indications or areas you’re targeting for approval and time lines around some of those? And when you’d expect you’d expect similar volume ramps to I think last quarter, you said breast volume picked up 40% right after that approval. And then my second question is just on the biopharma business. I think last quarter, you talked about plans to expand into China? Is that still on the table this year, the companies that we’ve heard from so far that have been reporting, it flagged material weakness in China. So table this year and thoughts around that.

Helmy Eltoukhy: Yes, I mean we have a list at CDxs that were either negotiations where they have signed on a bunch of other ESR1, but other indications as well. And I think that’s the opportunity ahead of us in terms of being able to partner with new classes of therapeutics biomarkers and other indications. We see hopefully a similar volume uplift in other indications in the future. In terms of China, we’re starting at zero right now. There’s a to upside at this point. But yes, we’re very pleased with the progress we’ve been making strong partnership with Adicon over there. We should be up and running by end of this year, and there’s a very strong pipeline in terms of biopharma partners that want to be able to sample in China.

There’s a vacuum right now in terms of sort of global companies that have the scale that we do that can operate in we see maybe that weakness that maybe others are facing there is a spring for us, and we are moving very nicely in terms of progress there.

Operator: We have no further questions. So I’ll turn the call back to the management team for any closing remarks.

Helmy Eltoukhy: Well, thank you.

Operator: Thank you, everyone, for joining us today. This concludes our call, and you may now disconnect your lines.